09 Dec 2013

Do Investors really have to choose between Rotten Eggs?

It seems like nary a day goes by without a new article popping up hating on diversification. Not because there’s anything really wrong with diversification, but because financial journalism seems to think there’s something wrong with diversification. Take a recent Market Watch article that explains that there’s nothing wrong with the theory of diversification, just that none of the asset classes are worth diversifying in. The only problem is the article leaves out managed futures… We throw it into the mix to see if it changes anything.

READ POST
03 Dec 2013

3 Paths to Commodity Exposure: Which one works best for you?

Each month, we write a post, crunch the data, and see how commodity ETF’s are performing against the commodity futures markets they are supposed to be tracking. But this concept only allows investors to make money when commodities are on the rise. More than a few people think that is rather limiting, and think the better way is to be able to make money in commodities whether they go up or down, whether commodities are rising or falling.

READ POST
02 Dec 2013

Managed Futures keeps positive performance rolling; Up 1.05% in November

The strong 2nd half performance typically witnessed from managed futures investors is coming to fruition as 2013 comes to a close. For the 2nd month in a row, the Barclayhedge BTOP 50 Index not only finished with a positive performance, but October and November’s monthly performance finished above the 1% mark {Disclaimer: Past performance is not necessarily indicative of future results}. Now the question is can the asset class finish the year on a positive note?

READ POST
26 Nov 2013

Question: Can CTA’s with $1 Billion AUM Trade Grains?

First, on an elementary level, you won’t find anything on the CME website detailing a restriction on managers exceeding an arbitrary assets under management, from entering into a position into any market, nevertheless any of the grain markets. That’s not to say the question is entirely off; the root of the question, and in our opinion, the far more intriguing factor is not that they can’t but that they mostly don’t. Here’s why.

READ POST

Archives

A grande vantagem do Alprostadil em creme Pentravan® é que sua ação é restrita ao local de aplicação. Tabaco juntocom visite este pode levar a uma condição denominada NAION ou estressado, pode ter sua ereção prejudicada e lubrificada, aumentando a elasticidade, ao preço acessível da Sildenafil, entrega rápida em 4-7 dias úteis sem taxa adicional.

logo